Collaborators

Mr Manj Gohel, Cambridge University, Areterial and Venous Research, 2013

Dr Claudia Monaco. Professor M Feldmann, Oxford University, Vascular Biology, 2012

Joseph Rafetto,, Harvard, Venous Disease and research, 2010

Guest Lectures

Deep Venous Valve Reconstruction Is Underutilized, Veith Symposium, New York, 2013

Risk Of Intracerebral Aneurysm Rupture During CEA Or CAS, Veith Symposium, New York, 2013

What Is The Cost For Screening And Treating Patients With High Grade Carotid Stenosis: How Effective Is It In Preventing Strokes, Veith Symposium, New York, 2013

The NICE guidelines in the Management of Varicose Veins, Vascular Society of GBI, 2013

Vein Diameter Is A Poor Determinate By Which To Ration Varicose Vein Treatment, Veith Symposium, New York, 2013

Should We Treat Truncal Reflux And Varicose Veins All In One Session, Veith Symposium, New York, 2013

Are The NICE 2013 UK Guidelines On The Management Of Venous Disease The Same As The SVS/AVF, Veith Symposium, New York, 2013

Challenging configurations and elegant solutions in complex AAA repair, Dutch Vascular Society, 2013

Endovenous Treatments, XIV International Symposium of Angiology and Vascular Surgery, - Oporto/ Portugal, 2013

Glue is the Answer, UIP, Boston, 2013

European Phlebology, UIP, Boston, 2013

Cost effectiveness in the management of venous disease, UIP, Boston, 2013

Flow dynamics in the venous system, UIP, Boston, 2013

Chronic Venous disease diagnosis and treatment, European Venous Forum, Belgrade, 2013

C2 Disease: Insurance coverage in UK, International Vein Congress, Miami, 2013

Treatment options, Clinical Outcome (Quality of Life) & Cost Benefit, International Vein Congress, Miami, 2013

Are venous anomalies in MS patients relevant or not, International Vein Congress, Miami, 2013

Cost effectiveness in Management of Venous Disease, Venous Forum, 2013

Patterns of recurrence after treatment of superficial disease, Venous Symposium, New York, 2013

Clinical presentation and ultrasound findings: Their significance in Patient management., Venous Symposium, New York, 2013

Who should perform venous investigations, Venous Forum, 2013

Risk of AAA rupture, Indian Vascular Meeting, Bangalore, 2013

Cost effectiveness in VVV treatment, EVC, Masstricht, 2013

Patterns of SSV reflux, EVC, Masstricht, 2013

Diagnosis and investigation of Pelvic Congestion Syndrome, ISVS, Miami, 2013

Single treatment is the best option, ISVS, Miami, 2013

Early results of the eSCOPE Trial, American Venous Forum, Phoenix, 2013

Contrast ultrasound evaluation of texture of carotid plaque, Munich Vascular Symposium, 2012

CEA is stiil superior to CAS in patients with an irradiated neck, Munich Vascular Symposium, 2012

Neurological Complications Of Sclerotherapy For Varicose Veins: Incidence And Prevention, Veith Symposium, New York, 2012

We Should Stop Screening For Asymptomatic Carotid Stenosis Even Though There Is A Substantial Incidence Of Silent Cerebral Events In These Patients: What Should We Do About It, Veith Symposium, New York, 2012

Are Venous Anomalies In MS Patients Relevant Or Not, Veith Symposium, New York, 2012

Dynamic Contrast Ultrasonography To Stratify Risk In Asymptomatic Carotid Stenosis Patients: How Does It Work, Veith Symposium, New York, 2012

It Does Not Matter Which Device For Truncal Vein Ablation, The Results Are The Same, Veith Symposium, New York, 2012

Cost Analysis Of Carotid Interventions In Asymptomatic Patients, Veith Symposium, New York, 2012

C2 Venous Disease Is Progressive: Its Treatment Should Be A Covered Insurance Benefit, Veith Symposium, New York, 2012

Tumenecentless VV treatments, ESVS, Bologna, 2012

EVAR for difficult Anatomy., VISCON, India, 2012

CCSVI is there a role?, BSET, Warwickshire, 2012

Carotid endarterectomy is superior to CAS in the irradiated neck., Portugese Vascular and Angology Society, 2012

Costs in the management of venus disease, Portugese Vascular and Angology Society, 2012

PMT is the optimal treatment for DVT., Australian College of Phlebology, 2012

Perioperative instructions in the intervention of VV, Australian College of Phlebology, 2012

Ultrasound in CCSVI., Australian College of Phlebology, 2012

Editor’s choice., Australian College of Phlebology, 2012

Haemodynamics and quality of life., Australian College of Phlebology, 2012

Segmental disease in venoius disease., Australian College of Phlebology, 2012

Guidelines for the management of VV., Australian College of Phlebology, 2012

No single treatment modality fits all., Australian College of Phlebology, 2012

Which sclerosant is best?, Australian College of Phlebology, 2012

Glue is the treatment of VV., Australian College of Phlebology, 2012

Neurological complications after foam sclerotherapy, Australian College of Phlebology, 2012

It matters not a jot which endothermal technique you use., Charing Cross Symposium, London, 2012

CCSVI a real entity., Charing Cross Symposium, London, 2012

Deep vein reconstruction., Charing Cross Symposium, London, 2012

Management of C2 Disease., EVC, Mastaricht, 2012

Guidelines in management of VV., EVC, Mastaricht, 2012

Foam sclerotharapy is possible in all patients with varicose veins, AVF, Florida, 2012

Quality of life tools can be used to ration varicose vein treatment, CACVS, Paris, 2012

Foam sclerotherapy is not neurologically safe, CACVS, Paris, 2012

Minimally invasive management of VVs, Balkan Venous Forum, Belgrad, 2011

Foam and liquid sclerotherapy, Balkan Venous Forum, Belgrad, 2011

How I do endothermal ablation, Saudi Phlebological Conference, Riyadh, 2011

Radiofrequency ablation for VVs, Saudi Phlebological Conference, Riyadh, 2011

LeGoo for vessel occlusion., Veith, New York, 2011

Ascending and descending theories of VV., Veith, New York, 2011

Quality of life tools cannot be used as a rationing tool., Veith, New York, 2011

UK based Guidelines on the management of varicose veins, Veith, New York, 2011

Guidelines in the Management of VV., Saudi Phlebological Conference, Riyadh, 2011

Endovenous ablation is better than open surgery, Turkish Vascular Society/ESVS:, Antyla, 2011

How do we make sense of these different ablative techniques?, European Venous Forum, Vienna, 2011

Carotid endarterectomy is still the gold standard., Turkish Vascular Society/ESVS:, Antyla, 2011

Endovenous ablative techniques an update, ESVS, Athens., 2011

980nm Laser vs VNUS closure a comparison for ablation, Mediteranean Vein Symposium:, Nice, 2011

Infrainguinal arterial disease: Endovascular or surgery, LIVE meeting, Greece, 2011

Cost effectiveness: how to justify endothermal ablation, LIVE meeting, Greece, 2011

Clampless surgery in renal access., Charing Cross International Symposium, London, 2011

Outcomes in Venous Disease., Charing Cross International Symposium, London, 2011

Cost effectiveness its importance in venous disease, Venous Forum RSM, London, 2011

Ablation in the management of Venous Ulcers., Australasian College of Phlebology, Melbourne, 2011

Ascending vs Descending theory of Vein development, Australasian College of Phlebology, Melbourne, 2011

Foam sclerotherapy is it safe., Australasian College of Phlebology, Melbourne, 2011

Endothermal ablation pros and cons, Australasian College of Phlebology, Melbourne, 2011

Outcomes and assessment in venous disease, Australasian College of Phlebology, Melbourne, 2011

How not to burn as an author an editors view, Australasian College of Phlebology, Melbourne, 2011

Endothermal ablation; what would the patients think if asked., CACVS, Paris, 2011

Being a Professor of Surgery., SARS, Dublin, 2011

Endothermal ablation in 2010., Belgian Vascular Meeting, Leuven, 2010

Contrast ultrasound in carotid plaque evaluation., Veith Symposium, New York, 2010

Iliac artery disease in cyclist., Veith Symposium, New York, 2010

Is foam sclerotherapy safe?, Veith Symposium, New York, 2010

Concommitant phlebectomy is essential., Turkish Vascular Society, Antalya, 2010

Is foam sclerotherapy the answer to truncal veins, Turkish Vascular Society, Antalya, 2010

Endothermal ablation., European Vascular Society, Amsterdam, 2010

Statistics at the next level., European Venous Forum, Antwerp, 2010

Endovascular management of popliteal aneurysm., Portugese Vascular Society, Oporto, 2010

Endovenous thermal ablation., Portugese Vascular Society, Oporto, 2010

Duplex surveillance in lower limb reconstruction., LIVE meeting, Greece, 2010

Venous Outcomes., LIVE meeting, Greece, 2010

Medical management of PTS., Venous Forum, London, 2010

Foam sclerotherapy is Safe., Charing Cross Symposium, London, 2010

Ascending and descending theory., European Vascular Course, Masstaricht, 2010

Surgery in tertiary access., Charing Cross Symposium, London, 2010

Anti-platlet agents and CEA., CACVS, Paris, 2010

Quality of life in Venous Disease and Expert panel,, American College of Phlebology, Palm Springs California., 2009

Outcomes in Venous Disease,, American Venous Forum, Hawaii, 2009

Endothermal techniques in Venous Disease., Balkan Venous Forum, 2009

Evidence of endothermal ablation., Italian Phlebology:, Italy, 2009

Outcome evaluation in venous disease, UIP, Monaco, 2009

Scientific basis of papers and presentation :, Interanional European Venous Forum, Copenhagen, 2009

Endovenous ablation the facts!, International Arabic Vascular Society:, Saudi Arabia, 2009

EVAR in the high risk patient, International Arabic Vascular Society, Saudi Arabia, 2009

Carotid endarterectomy is the gold standard, International Arabic Vascular Society:, Saudi Arabia, 2009

Endothermal ablation summary of results., Charing Cross Symposium:, 2009

Sense or nonsense of follow up after conventional vascular surgery, Belgium Symposium, Leuven:, 2008

International Venous Registry ., American College of Phlebology, Florida:, 2008

Iliac compression effect on cyclists.:, Veith Symposium, New York, 2008

Lower limb ischaemia. . :, ESVS, Nice, 2008

International venous Registry, European Venous Forum, Barcelonna, 2008

How an editor handles and considers a submitted paper, Vascular symposium:, Larissa, 2008

Staged or combined management is preferable in patients with coronary artery disease and AAA? Has the application of endovascular treatment influenced the clinical practice?", Vascular symposium:, Larissa, 2008

International Venous Registry, Charing Cross Symposium, 2008

Multiple visits versus single.:, Charing Cross Symposium, 2008

Management of ischaemic leg. :, Diabetic Association, 2008

Management of leg ulcers., Turkish Wound Society, 2007

Supervised exercise a forgotten entity., Veith Symposium, New York, 2007

International Venous Registry ., Veith Symposium, New York, 2007

Cognitive effects of Carotid intervention., RSM, 2007

Laser Vein ablation:, Pros and Cons International Society of Vascular Surgery., Milan, 2007

International Venous Registry:, Serbian Phlebological Society, Belgrade, 2007

Vein Graft Surveillance, RSM, London, 2007

International Venous Registry:, European Society of Vascular Surgery, Madrid, 2007

Is EVAR the best treatment choice fof AAA., Larissa, Greece, 2007

International Venous Registry: : June 2007, European Venous Forum, Istanbul, 2007

Quality of life in venous disease., Galway, 2007

Complex Renal access. :, IV Renal Access Meeting, 2007

International Venous Registry :, Charing Cross Symposium, 2007

Methods of venous ablation, RSM, 2007

Open Surgery is still the best technique to ablate the great saphenous vein., Veith Symposium, New York, 2006

DVT Prophylaxis: a Cinderella?, Vascular symposium, Oporto, 2006

European Venous Registery., Vascular symposium, Oporto, 2006

Superfical venous surgery for venous ulceration, European Society for Vadcular surgery, Prague, 2006

Deep Vein Reconstruction, VSS/BVF meeting, London, 2006

Stenting for small AAA, Imperatives Course, Coventry:, 2006

Open surgery is the answer to varicose veins., Charing Cross Symposium, London, 2006

Oh Boy do I feel Old. Symposia on Long Saphenous Vein ablation, American Venous Forum, Miami, 2006

Management of the ischaemic complications of renal access, Veith Symposium, New York, 2005

This house believes that varicose vein surgery should be available on the NHS., Vascular Surgical Society, Bournemouth, 2005

Endovenous laser ablation, Vascular Symposium, Oporto, Portugal, 2005

The role of surgery in the management of leg ulcers, Vascular Symposium, OPorto, Portugal;, 2005

Management of difficult access, Renal Access Symposium, Amsterdam, 2005

Kippel Trenawny Syndrome, JVRG, 2005

Open Repair is the method of choice for ruptured Aortic Aneurysm Repair, Charing Cross Symposium, London, 2005

Numerous Guest Lectures on vascular disease on average 40 per annum, Worldwide

Cost effectiveness of VV treatment, Charing Cross International Symposium

Research Staff

Lane,T

Lane,TRA

Onida,S

Research Student Supervision

Lane,T, Varicose vein outcomes